US 8436154
Crystallizing method of erythromycin
granted A61PA61P31/04
Quick answer
US patent 8436154 (Crystallizing method of erythromycin) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P31/04